Authors: Wilner, KD Tensfeldt, TG Baris, B Smolarek, TA Turncliff, RZ Colburn, WA Hansen, RA

Citation: Kd. Wilner et al., Single- and multiple-dose pharmacokinetics of ziprasidone in healthy youngand elderly volunteers, BR J CL PH, 49, 2000, pp. 15S-20S

Authors: Everson, G Lasseter, KC Anderson, KE Bauer, LA Carithens, RL Wilner, KD Johnson, A Anziano, RJ Smolarek, TA Turncliff, RZ

Citation: G. Everson et al., The pharmacokinetics of ziprasidone in subjects with normal and impaired hepatic function, BR J CL PH, 49, 2000, pp. 21S-26S

Authors: Aweeka, F Jayesekara, D Horton, M Swan, S Lambrecht, L Wilner, KD Sherwood, J Anziano, RJ Smolarek, TA Turncliff, RZ

Citation: F. Aweeka et al., The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function, BR J CL PH, 49, 2000, pp. 27S-33S

Authors: Smolarek, TA Blough, RI Foster, RS Ulbright, TM Palmer, CG Heerema, NA

Citation: Ta. Smolarek et al., Cytogenetic analyses of 85 testicular germ cell tumors: Comparison of postchemotherapy and untreated tumors, CANC GENET, 108(1), 1999, pp. 57-69

Authors: Pollack, VA Savage, DM Baker, DA Tsaparikos, KE Sloan, DE Moyer, JD Barbacci, EG Pustilnik, LR Smolarek, TA Davis, JA Vaidya, MP Arnold, LD Doty, JL Iwata, KK Morin, MJ

Citation: Va. Pollack et al., Inhibition of epidermal growth factor receptor-associated tyrosine phosphorylation in human carcinomas with CP-358,774: Dynamics of receptor inhibition in situ and antitumor effects in athymic mice, J PHARM EXP, 291(2), 1999, pp. 739-748

Authors: McCormack, FX Smolarek, TA Menon, AG

Citation: Fx. Mccormack et al., Lymphangioleiomyomatosis and leiomyoma - Possibility of shared genetic origins?, LUNG BIOL H, 131, 1999, pp. 373-386